FULC - Fulcrum Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FULC is currently covered by 5 analysts with an average price target of $11.73. This is a potential upside of $2.74 (30.48%) from yesterday's end of day stock price of $8.99.

Fulcrum Therapeutics's activity chart (see below) currently has 114 price targets and 83 ratings on display. The stock rating distribution of FULC is 42.86% HOLD and 57.14% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.17% with an average time for these price targets to be met of 137.08 days.

Highest price target for FULC is $12, Lowest price target is $4, average price target is $9.4.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 28-Jul-2025. First documented stock forecast 11-Aug-2019.

Currently out of the existing stock ratings of FULC, 3 are a HOLD (42.86%), 4 are a BUY (57.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$12

$3.01 (33.48%)

$4

2 months 14 days ago
(28-Jul-2025)

11/19 (57.89%)

$4.41 (58.10%)

129

Buy

$9

$0.01 (0.11%)

$15

4 months 14 days ago
(28-May-2025)

4/11 (36.36%)

$1.93 (27.30%)

159

Buy

$12

$3.01 (33.48%)

$4

4 months 20 days ago
(22-May-2025)

2/3 (66.67%)

$5.56 (86.34%)

184

Buy

$10

$1.01 (11.23%)

4 months 28 days ago
(14-May-2025)

0/3 (0%)

$3.4 (51.52%)

Hold

$4

$-4.99 (-55.51%)

$4

10 months 29 days ago
(13-Nov-2024)

2/3 (66.67%)

$0.68 (20.48%)

19

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FULC (Fulcrum Therapeutics) average time for price targets to be met?

On average it took 137.08 days on average for the stock forecasts to be realized with a an average price target met ratio 53.17

Which analyst has the current highest performing score on FULC (Fulcrum Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the most public recommendations on FULC (Fulcrum Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 7 price targets and 5 ratings on FULC

Which analyst is the currently most bullish on FULC (Fulcrum Therapeutics)?

Corinne Jenkins with highest potential upside - $6.01

Which analyst is the currently most reserved on FULC (Fulcrum Therapeutics)?

Tazeen Ahmad with lowest potential downside - -$6.99

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?